Remove 2002 Remove Biosimilars Remove Diabetes
article thumbnail

A history of Johnson & Johnson

pharmaphorum

During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. Weldon became the Chairman and CEO of J&J in 2002. Acquisitions post-Janssen. Between 1976 and 1989, James E. Burke was chairman and CEO of J&J. billion the following February.

Vaccines 126
article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Some companies accept the offered period and open doors to biological drugs or biosimilars. Indication: Type 2 Diabetes Mellitus Victoza is a non-insulin, anti-diabetic medicine used for the treatment of type 2 diabetes and to reduce the risk of cardiovascular events associated with the disease.

article thumbnail

A history of Pfizer

pharmaphorum

Others rapidly followed, including Glucotrol, aimed at diabetics, and Procardia, an anti-hypertensive. Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016.